about
Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus InfectionAntimicrobial photodynamic therapy to kill Gram-negative bacteriaTriggering Receptor Expressed on Myeloid Cells (TREM) family and the application of its antagonistsRecent developments on coronavirus main protease/3C like protease inhibitors.Recent Patents on development of nucleic acid-based antiviral drugs against seasonal and pandemic influenza virus infections.Control of mycobacterium tuberculosis infection by glutathione.Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy.PEGylated liposomal vancomycin: a glimmer of hope for improving treatment outcomes in MRSA pneumonia.Synthesis of substituted N-aryl-N'-Sulfamoyloxazolidin-2-ones with potential antibacterial activity.Progress towards recombinant anti-infective antibodies.Topical antimicrobials for burn infections - an updatePatent landscape of countermeasures against smallpox and estimation of grant attraction capability through patent landscape data.Commercial development and application of type A lantibiotics.Direct modification of bioactive phenothiazines by exposure to laser radiation.Topical antimicrobials for burn wound infectionsViral gastroenteritis in adults.Recent patents regarding essential oils and the significance of their constituents in human health and treatment.Climate change, climate variability and brucellosis.Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.Development of small-molecule inhibitors of Raf.Rediscovering the antibiotics of the hive.Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.The present situation of human taeniases and cysticercosis in Asia.Patented HIV-1 integrase inhibitors (1998-2005).Recent progress in pharmacological research of antioxidants in pathological conditions: cardiovascular health.Promising drugs against tuberculosis.Recent advances in flavivirus antiviral drug discovery and vaccine development.C5a, a therapeutic target in sepsis.An insight on the leading HIV entry inhibitors.Current status and future of antifungal therapy for systemic mycoses.Pegylated interferons for the treatment of chronic hepatitis B.Attack on the scourge of tuberculosis: patented drug targets.Inhibition of HIV-1 entry into cells.Anti-infective quinone derivatives of recent patents.Novel concepts for anti-infective activity of cytokines, chemokines and diverse agents.Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux.Antimicrobial properties of organosulfur anti-infectives: a review of patent literature 1999-2005.Light activated compounds as antimicrobial agents - patently obvious?Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides.
P1433
Q22305779-914BED57-2911-4A58-A0E3-AABE1B18A5B3Q26866247-8E1B0385-1AF1-4B32-AC6D-D824CEA81138Q28610495-CF2BA072-ECE1-45C1-B7C4-EB890AC18341Q30352286-38F8002E-FA6D-4A2D-9612-1D99879B0D23Q30367392-CF4E544D-5447-41A4-B7C3-DE2C03073A54Q30381670-0F74AE3E-74E2-4837-84D8-3A417FF31325Q30387251-28BC03A5-8C6F-4FEA-86AC-AA03D1D3E70FQ30418628-59C87F66-CBD7-4090-BC2D-07C80B7BBB4DQ33316541-07D0AE67-E56E-44A4-B6BF-B7F0563C89CDQ33568256-BD550EE3-8CC9-48EC-90ED-2F7A7D38AF0BQ33600002-38883749-56A6-4E89-8D47-72F476A5D46DQ33672116-AD1F3280-B6FD-4EC7-AB69-2E35E8AD73B5Q33881413-D7D8B2EC-7D91-45B5-85C0-40B69CA371DEQ33881420-8DF1D36E-A3E0-4E4E-AEF5-F1A8B429692FQ34111992-51B00255-3C1A-4E00-9EBE-7F6A24A6FE5EQ34157829-197EFC09-74E8-4EA3-BFFF-03D2DA612038Q34277849-98E8775B-F1C5-47DF-92E6-63B677E329F2Q34370914-65DA80D6-C418-4D83-B1AC-45E1174F805AQ34470703-E6891255-85F4-4D0E-94E5-02B92E60C263Q34587579-DA3A9D1D-84F0-4446-B7CC-0192AFB76D96Q34741761-5860786D-1137-4BD5-8BC2-DDCD69C257BFQ34996925-AEBBCD5F-271C-4ED7-A44B-D911A2FFF932Q35531731-B8F50131-5AE1-4420-AD8B-FC05A4418745Q35598676-681F5FEF-1EA2-49D9-B811-F3BFA9573ED1Q37067128-59A92514-D69D-459E-A9A7-477A234E4419Q37067133-A8D65E4E-A163-4DAF-B76F-1AED454FE3F9Q37067135-24293381-DE1C-4222-BD17-D4C7E5F15FCFQ37067139-7817401E-9437-471D-93DA-43070E6B531DQ37067143-19EC1439-5109-4D3B-850F-27D7ED9F90BAQ37067148-67BA1F98-BDF3-4362-BDC4-D84D8F1AC765Q37067153-E53EE6AA-34C5-4FCA-81C1-1E15801D2B6AQ37067158-CE87DA9B-D3A8-41FC-B971-3A1BB4D6F28EQ37067162-A8E4A665-71BC-4610-890B-73B2D2115D9DQ37067166-9003F031-7052-4B65-A503-67DF7E6D1CF8Q37067171-9D0994FB-DCCE-4654-A646-82D1AFAB8056Q37067175-102EFB89-70ED-4EBA-8980-008A8FE0C27EQ37067179-F4B6534C-3004-406A-AFD7-4F2ECBCE09FFQ37067184-A2E60113-2A64-4C46-BFA5-FED939C32682Q37067187-02BBD7F3-5C5C-46D0-8444-4AAB57B036DAQ37067192-E9CADD7D-ACFE-4D52-97B8-5965D9404F85
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
name
Recent patents on anti-infective drug discovery
@ast
Recent patents on anti-infective drug discovery
@en
Recent patents on anti-infective drug discovery
@es
Recent patents on anti-infective drug discovery
@it
Recent patents on anti-infective drug discovery
@nl
type
label
Recent patents on anti-infective drug discovery
@ast
Recent patents on anti-infective drug discovery
@en
Recent patents on anti-infective drug discovery
@es
Recent patents on anti-infective drug discovery
@it
Recent patents on anti-infective drug discovery
@nl
prefLabel
Recent patents on anti-infective drug discovery
@ast
Recent patents on anti-infective drug discovery
@en
Recent patents on anti-infective drug discovery
@es
Recent patents on anti-infective drug discovery
@it
Recent patents on anti-infective drug discovery
@nl
P3181
P1055
P1058
P1156
5800173403